Cite
HARVARD Citation
Cytryn, S. et al. (2021). Durvalumab consolidation therapy in a patient with stage IIIB unresectable NSCLC harboring a MET exon 14 splice site alteration. Lung cancer. pp. 15-17. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cytryn, S. et al. (2021). Durvalumab consolidation therapy in a patient with stage IIIB unresectable NSCLC harboring a MET exon 14 splice site alteration. Lung cancer. pp. 15-17. [Online].